Nathan Brand

Also affiliated with University of New Mexico, University of California, San Francisco, Global Brain Health Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “IFN-λ4 is associated with increased risk and earlier occurrence of several common infections in African children”.

IFN-λ4 is associated with increased risk and earlier occurrence of several common infections in African children

Genes and Immunity(2021)10.1038/s41435-021-00127-7

N/A

0.360DataRank · unranked

10 citations

Robert Morrison, Adeola Obajemu, Almahamoudou Mahamar, Sungduk Kim, Oumar Attaher +13 more

Moving towards an evidence-informed cancer control strategy: A scoping review of oncology research in Kenya

Journal of Cancer Policy(2020)10.1016/j.jcpo.2020.100219

N/A

0DataRank · unranked

6 citations

Mina Akhavan, Gershim Asiki, Nathan Brand, Mishka Kohli Cira, Zeinab Gura +6 more

IFN-λ4 is associated with increased risk and earlier occurrence of gastrointestinal, respiratory and malarial infections in Malian children

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.02.24.962688

N/A

0DataRank · unranked

4 citations

Robert Morrison, Adeola Obajemu, Almahamoudou Mahamar, Sungduk Kim, Oumar Attaher +13 more

Report from the first Tanzania Liver Cancer Conference: a call for action to unite in the fight against liver cancer in Sub-Saharan Africa, 17–18 March 2023, Dar es Salaam, Tanzania

ecancermedicalscience(2023)10.3332/ecancer.2023.1543

N/A

0DataRank · unranked

0 citations

Erick M. Mbuguje, Jared M. Alswang, Nathan Brand, Andrew Swallow, Deogratius Mwanakulya +6 more

Novel dual action PARP and microtubule polymerization inhibitor AMXI-5001 powerfully inhibits growth of esophageal carcinoma both alone and in combination with radiotherapy

American Journal of Cancer Research(2024)10.62347/uhlu6598

N/A

0DataRank · unranked

4 citations

Nathan Brand